147 related articles for article (PubMed ID: 23744032)
1. [MYC amplification distinguishes between atypical vascular lesion and radiation-induced angiosarcoma of the breast].
Hafner C
Hautarzt; 2013 Jul; 64(7):533-4. PubMed ID: 23744032
[No Abstract] [Full Text] [Related]
2. Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases.
Mentzel T; Schildhaus HU; Palmedo G; Büttner R; Kutzner H
Mod Pathol; 2012 Jan; 25(1):75-85. PubMed ID: 21909081
[TBL] [Abstract][Full Text] [Related]
3. Angiosarcoma, radiation-associated angiosarcoma, and atypical vascular lesion.
Lucas DR
Arch Pathol Lab Med; 2009 Nov; 133(11):1804-9. PubMed ID: 19886715
[TBL] [Abstract][Full Text] [Related]
4. MYC amplification and overexpression in primary cutaneous angiosarcoma: a fluorescence in-situ hybridization and immunohistochemical study.
Shon W; Sukov WR; Jenkins SM; Folpe AL
Mod Pathol; 2014 Apr; 27(4):509-15. PubMed ID: 24091875
[TBL] [Abstract][Full Text] [Related]
5. MYC immunohistochemistry in angiosarcoma and atypical vascular lesions: practical considerations based on a single institutional experience.
Udager AM; Ishikawa MK; Lucas DR; McHugh JB; Patel RM
Pathology; 2016 Dec; 48(7):697-704. PubMed ID: 27780597
[TBL] [Abstract][Full Text] [Related]
6. Postirradiation epithelioid angiosarcoma of the breast: a case report with immunohistochemical and electron microscopic study.
Seo IS; Min KW
Ultrastruct Pathol; 2003; 27(3):197-203. PubMed ID: 12775509
[TBL] [Abstract][Full Text] [Related]
7. Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expression.
Fraga-Guedes C; André S; Mastropasqua MG; Botteri E; Toesca A; Rocha RM; Peradze N; Rotmensz N; Viale G; Veronesi P; Gobbi H
Breast Cancer Res Treat; 2015 May; 151(1):131-40. PubMed ID: 25893585
[TBL] [Abstract][Full Text] [Related]
8. Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions.
Guo T; Zhang L; Chang NE; Singer S; Maki RG; Antonescu CR
Genes Chromosomes Cancer; 2011 Jan; 50(1):25-33. PubMed ID: 20949568
[TBL] [Abstract][Full Text] [Related]
9. MYC gene amplification by fluorescence in situ hybridization and MYC protein expression by immunohistochemistry in the diagnosis of cutaneous angiosarcoma: Systematic review and appropriate use criteria.
Motaparthi K; Lauer SR; Patel RM; Vidal CI; Linos K
J Cutan Pathol; 2021 Apr; 48(4):578-586. PubMed ID: 33128474
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous angiosarcoma and atypical vascular lesions of the skin and breast after radiation therapy for breast carcinoma.
Fineberg S; Rosen PP
Am J Clin Pathol; 1994 Dec; 102(6):757-63. PubMed ID: 7801888
[TBL] [Abstract][Full Text] [Related]
11. The utility of MYC and FLT4 in the diagnosis and treatment of postradiation atypical vascular lesion and angiosarcoma of the breast.
Cornejo KM; Deng A; Wu H; Cosar EF; Khan A; St Cyr M; Tomaszewicz K; Dresser K; O'Donnell P; Hutchinson L
Hum Pathol; 2015 Jun; 46(6):868-75. PubMed ID: 25864386
[TBL] [Abstract][Full Text] [Related]
12. C-MYC positive angiosarcoma of skin and breast following MammoSite® treatment.
Tidwell WJ; Haq J; Kozlowski KF; Googe PB
Dermatol Online J; 2015 Oct; 21(10):. PubMed ID: 26632799
[TBL] [Abstract][Full Text] [Related]
13. Can c-myc amplification reliably discriminate postradiation from primary angiosarcoma of the breast?
Laé M; Lebel A; Hamel-Viard F; Asselain B; Trassard M; Sastre X; Kirova YM
Cancer Radiother; 2015 May; 19(3):168-74. PubMed ID: 25863565
[TBL] [Abstract][Full Text] [Related]
14. Fine-needle aspiration biopsy of postradiation epithelioid angiosarcoma of breast.
Vesoulis Z; Cunliffe C
Diagn Cytopathol; 2000 Mar; 22(3):172-5. PubMed ID: 10679998
[TBL] [Abstract][Full Text] [Related]
15. MYC expression has limited utility in the distinction of undifferentiated radiation-associated sarcomas from sporadic sarcomas and sarcomatoid carcinoma.
Mito JK; Qian X; Jo VY; Doyle LA
Histopathology; 2020 Oct; 77(4):667-672. PubMed ID: 32506510
[TBL] [Abstract][Full Text] [Related]
16. Radiation-induced breast angiosarcoma with a confirmative feature of c-MYC amplification.
Tajima S; Mochizuki R; Sugimura H; Hoshi S
Jpn J Clin Oncol; 2014 Jul; 44(7):702-3. PubMed ID: 24903854
[No Abstract] [Full Text] [Related]
17. MYC and NOTCH1-positive postradiation cutaneous angiosarcoma of the breast.
Sheu TG; Hunt KK; Middleton LP
Breast J; 2021 Mar; 27(3):264-267. PubMed ID: 33527629
[TBL] [Abstract][Full Text] [Related]
18. Post-radiation vascular lesions of the breast.
Ronen S; Ivan D; Torres-Cabala CA; Curry JL; Tetzlaff MT; Aung PP; Nagarajan P; Suster S; Prieto VG
J Cutan Pathol; 2019 Jan; 46(1):52-58. PubMed ID: 30251277
[TBL] [Abstract][Full Text] [Related]
19. Angiosarcoma after conservative treatment and radiation therapy for adenocarcinoma of the breast.
Lamblin G; Oteifa M; Zinzindohoue C; Isaac S; Termine L; Bobin JY
Eur J Surg Oncol; 2001 Mar; 27(2):146-51. PubMed ID: 11289749
[TBL] [Abstract][Full Text] [Related]
20. Endoglin (CD105) and claudin-5 expression in cutaneous angiosarcoma.
Hara H
Am J Dermatopathol; 2012 Oct; 34(7):779-82. PubMed ID: 23000880
[No Abstract] [Full Text] [Related]
[Next] [New Search]
